These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1409107)

  • 1. Metastatic capacity and differentiation in murine melanoma cell lines. A morphometric study.
    Maiorana A; Cavallari V; Maiorana MC; Fano RA; Scimone S; Fante R; Garbisa S
    Pathol Res Pract; 1992 Jun; 188(4-5):657-62. PubMed ID: 1409107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan.
    Kure S; Yoshie O; Aso H
    Jpn J Cancer Res; 1987 Nov; 78(11):1238-45. PubMed ID: 2961717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of new metastatic variants of B16 melanoma under different culture conditions.
    Aubert C; Ali-Mehidi S; Rouge F; Voulot C
    Pigment Cell Res; 1992 Feb; 5(1):12-24. PubMed ID: 1631017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.
    Nicolson GL; Inoue T; Van Pelt CS; Cavanaugh PG
    Cancer Res; 1990 Feb; 50(3):515-20. PubMed ID: 2297694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic potential and multidrug resistance correlation in the B16 melanoma system.
    Staroselsky AN; Mahlin T; Savion N; Klein O; Nordenberg J; Donin N; Michowitz M; Leibovici J
    J Exp Ther Oncol; 1996 Jul; 1(4):251-9. PubMed ID: 9414412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential resistance of B16 wild-type and F10 cells to mechanical trauma in vitro.
    Weiss L; Elkin G; Barbera-Guillem E
    Invasion Metastasis; 1993; 13(2):92-101. PubMed ID: 8225856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells.
    Kameyama K; Vieira WD; Tsukamoto K; Law LW; Hearing VJ
    Int J Cancer; 1990 Jun; 45(6):1151-8. PubMed ID: 2161802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
    Parratto NP; Odebralski JM; Kimura AK
    Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic variants of the B16 melanoma: metastasis is related to environmental conditions. Phenotypic changes in vitro and metastatic colonization potential in nude mice.
    Aubert C
    Melanoma Res; 1995 Jun; 5(3):139-46. PubMed ID: 7640514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged in vitro culture modifies the surface lipid composition of murine melanoma cell lines.
    Moretti S; Montorfano G; Rapelli S; Berra B
    Ital J Biochem; 1997 Dec; 46(4):187-94. PubMed ID: 9541865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of cell surface properties on the arrest of circulating melanoma cells.
    Poste G
    Prog Clin Biol Res; 1980; 41():737-45. PubMed ID: 7192863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
    Yu HR; Schultz RM
    Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased experimental metastatic capacity of a murine melanoma following induction of differentiation.
    Bennett DC; Dexter TJ; Ormerod EJ; Hart IR
    Cancer Res; 1986 Jul; 46(7):3239-44. PubMed ID: 3708559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
    Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
    Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
    Stackpole CW
    Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones.
    Lester BR; McCarthy JB; Sun ZQ; Smith RS; Furcht LT; Spiegel AM
    Cancer Res; 1989 Nov; 49(21):5940-8. PubMed ID: 2477150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between cellular procoagulant activity and metastatic capacity of B16 mouse melanoma variants.
    Gilbert LC; Gordon SG
    Cancer Res; 1983 Feb; 43(2):536-40. PubMed ID: 6848176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.